Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-019-01592-x
Abstract: Background Pseudomyxoma peritonei (PMP) is a rare malignancy, and there is insufficient evidence about systemic chemotherapy for this disease. Methods We retrospectively evaluated the efficacy and safety of a chemotherapeutic regimen with 5-fluorouracil and oxaliplatin… read more here.
Keywords: pseudomyxoma peritonei; modified folfox6; unresectable pseudomyxoma; patients unresectable ... See more keywords
A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies
Sign Up to like & getrecommendations! Published in 2020 at "Advances in Therapy"
DOI: 10.1007/s12325-020-01358-2
Abstract: Introduction In patients with advanced gastric cancer refractory to chemotherapy, the treatment options are limited. Via this phase II study, we aimed to assess the efficacy and safety of oxaliplatin in combination with 5-fluorouracil and… read more here.
Keywords: advanced gastric; gastric cancer; modified folfox6; cancer refractory ... See more keywords